Mitochondrial Alteration Clinical Trial
Official title:
Mitochondrial Targeted Biofuels as Countermeasures Against Chemical Threats
The purpose of the study is to determine in vitro effects on mitochondrial function of selected chemical agents in human cells, and assess the capability of a cell-permeable succinate prodrug to attenuate toxic effects The project aims at repurposing this recent pharmaceutical discovery, currently being developed for treatment of toxic exposure, for an expanded indication to treat chemically induced mitochondrial toxicity.
The study duration per subject will be approximately 15 minutes to complete the one time blood collection. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03727646 -
Nicotinamide Riboside in LVAD Recipients
|
Early Phase 1 | |
| Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
| Recruiting |
NCT06167135 -
Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort
|
||
| Withdrawn |
NCT04756674 -
The Impact of Covid-19 on Skeletal Muscle
|
||
| Completed |
NCT04193566 -
Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes
|
Phase 4 | |
| Completed |
NCT03052595 -
Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance
|
||
| Not yet recruiting |
NCT06191965 -
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
|
Phase 2/Phase 3 | |
| Completed |
NCT03251144 -
Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)
|
Phase 1/Phase 2 | |
| Completed |
NCT03119350 -
Mitochondrial Energy Metabolism in Obese Women
|
N/A |